By Bob DeMarco
See these updates:
See these updates.
Generic Donepezil, Aricept, $27 for 90 days from Costco
Donepezil (Aricept) Price Falls by 90 Percent
The Wall Street Journal reported today that...
India's Wockhardt Ltd. said Wednesday it has received tentative approval from the U.S. Food and Drug Administration to sell the generic version of Forest Laboratories Inc.'s Alzheimer's disease and dementia drug, Namenda.
Wockhardt said it has reached a settlement with Forest on the drug's patent litigation, under which the Indian company can launch the copycat version months before patent expiration or as soon as any other copycat is launched.
Forest Laboratories, Inc. (FRX) recently settled its patent litigation for Namenda (memantine).
Under the settlement agreements, the first generic versions of memantine would be able to enter the market on January 11, 2015.
- 10 Things a Person Living with Dementia Would Tell You If They Could
- 3 Ways to Get an Alzheimer's Patient to Eat More Food
- What's the Difference Between Alzheimer's and Dementia?
- Test Your Memory for Alzheimer's (5 Best Memory Tests)
- Dementia and Eight Types of Dementia
- Communicating in Alzheimer's World
- Are Alzheimer's Caregivers the Forgotten?
- The First Sign of Alzheimer's Short Term Memory Loss
- Urinary Tract Infections Can Hasten Memory Loss in Alzheimer's Patients
- The Seven Stages of Alzheimer's
- Problems with Balance, Walking, Falling Can Be an Early Sign of Dementia
- What is Alzheimer's Disease